Ligazid 5 mg (Tablet)
Unit Price: ৳ 18.00 (3 x 10: ৳ 540.00)
Strip Price: ৳ 180.00
Medicine Details
Category | Details |
---|---|
Generic | Linagliptin |
Company | Eskayef pharmaceuticals ltd |
Indications
- Treatment of type 2 diabetes mellitus
- Improving glycaemic control in adults
- Monotherapy for inadequately controlled patients
- Combination therapy with metformin and sulphonylurea
- Intolerance or contraindication due to renal impairment
Pharmacology
- Inhibitor of DPP-4 (dipeptidyl peptidase-4) enzyme
- Increases concentrations of active incretin hormones
- Stimulates insulin release from pancreatic beta cells
- Decreases glucagon secretion from pancreatic alpha cells
Dosage & Administration
- 5 mg once daily
- Maintenance of metformin dose if used in combination
- Consideration of lower dose of sulphonylurea in combination therapy
- No dose adjustment required for patients with renal impairment
- Can be taken with or without a meal at any time of the day
Interaction
- Weak competitive inhibitor of CYP3A4
- Weak to moderate mechanism-based inhibitor of CYP3A4
- Low risk for clinically meaningful interactions with other medicinal products
Contraindications
- Hypersensitivity to the active substance or excipients
Side Effects
- Hypoglycaemia
- Nasopharyngitis
- Cough
- Pancreatitis in combination therapy
Pregnancy & Lactation
- Pregnancy category B
- Use during pregnancy only if clearly needed
- Unknown excretion into breast milk
Precautions & Warnings
- Hypersensitivity to the active substance or excipients
Therapeutic Class
- Dipeptidyl Peptidase-4 (DPP-4) inhibitor
Storage Conditions
- Dry place away from light and heat
- Keep out of the reach of children
Chemical Structure
- Molecular Formula: C25H28N8O2
Common Questions about Ligazid 5 mg Tablet
- Inhibitor of DPP-4 enzyme
- Treatment of type 2 diabetes mellitus
- Duration of use until improvement in health condition
- Frequency and timing of dosage
- Instructions for storage and disposal
- Quick tips for usage